The FDA has approved a prefilled syringe formulation of Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) that allows patients to self-inject the medication.

The American Society of Clinical Oncology presents updated recommendations for fertility preservation (FP) in people with cancer.

Icotrokinra appears to be an effective treatment for adolescents with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

The inability to pay for health care has reached its highest point in the United States, according to the results of a survey.

People covered by Medicaid are just as likely as those with private insurance to face a copay or other charge for sending a message to their physician or other provider through a portal.

All-cause mortality increased in 2020 to 2021 nationwide, with a slower increase in Medicaid expansion states, according to a study.

Children born to anti-Ro antibody-positive mothers do not exhibit a greater prevalence of allergic, neurodevelopmental, or autoimmune conditions.

Risk factors for mortality in AAV-ILD included age, a history of smoking, a UIP pattern, acute exacerbations of ILD, and the microscopic polyangiitis subtype.

Prescribing medical cannabis to patients with chronic health conditions may improve health-related quality of life (HRQL).

No association was observed between serious infection risk and Janus kinase inhibitor use in patients with immune-mediated inflammatory skin disease.

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) may reduce the risk of dementia or cognitive impairment.

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.